GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » Net Margin %

SLS BIO Co (XKRX:246250) Net Margin % : 6.52% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. SLS BIO Co's Net Income for the three months ended in Mar. 2024 was ₩134 Mil. SLS BIO Co's Revenue for the three months ended in Mar. 2024 was ₩2,048 Mil. Therefore, SLS BIO Co's net margin for the quarter that ended in Mar. 2024 was 6.52%.

The historical rank and industry rank for SLS BIO Co's Net Margin % or its related term are showing as below:

XKRX:246250' s Net Margin % Range Over the Past 10 Years
Min: -46.01   Med: 0.7   Max: 26.28
Current: 8.68


XKRX:246250's Net Margin % is ranked better than
73.76% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.7 vs XKRX:246250: 8.68

SLS BIO Co Net Margin % Historical Data

The historical data trend for SLS BIO Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co Net Margin % Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only 8.45 -7.77 0.70 26.28 15.89

SLS BIO Co Quarterly Data
Sep22 Dec22 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial 40.83 - 1.68 16.48 6.52

Competitive Comparison of SLS BIO Co's Net Margin %

For the Diagnostics & Research subindustry, SLS BIO Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SLS BIO Co's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SLS BIO Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where SLS BIO Co's Net Margin % falls into.



SLS BIO Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

SLS BIO Co's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1434.046/9023.399
=15.89 %

SLS BIO Co's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=133.642/2048.418
=6.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SLS BIO Co  (XKRX:246250) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


SLS BIO Co Net Margin % Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SLS BIO Co (XKRX:246250) Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines